Low dose verapamil as an adjunct therapy for medically refractory epilepsy – An open label pilot study

This publication has 10 references indexed in Scilit:

• The possible use of the L-type calcium channel antagonist verapamil in drug-resistant epilepsy
  Expert Review of Neurotherapeutics, 2015
• A pilot double-blind trial using verapamil as adjuvant therapy for refractory seizures
  Epilepsy Research, 2014
• Efficacy of verapamil as an adjunctive treatment in children with drug-resistant epilepsy: A pilot study
  Seizure: European Journal of Epilepsy, 2014
• Adjunctive use of verapamil in patients with refractory temporal lobe epilepsy: A pilot study
  Epilepsy & Behavior, 2013
• Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
  Epilepsia, 2010
• Drug resistance in brain diseases and the role of drug efflux transporters
  Nature Reviews Neuroscience, 2005
• Potential Role of Drug Transporters in the Pathogenesis of Medically Intractable Epilepsy
  Epilepsia, 2005
• Interaction of Antiepileptic Drugs with Human P-Glycoprotein in Vitro
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood–brain barrier: evidence from microdialysis experiments in rats
  Neuroscience Letters, 2002
• Role of Multidrug Transporters in Pharmacoresistance to Antiepileptic Drugs
  The Journal of Pharmacology and Experimental Therapeutics, 2002